PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE

Bibliographic Details
Main Authors: Viviana Amato, Stefania Fusani, Cristina Papayannidis, Jacopo Nanni, Antonio Curti, Francesco Marchesi, Maurizio Fanciulli, Giorgia Simonetti, Gerardo Musuraca, Giovanni Marconi, Michele Gottardi, Alessandra Sperotto, Alessandra Rossi, Alessio Maria Edoardo Maraglino, Simona Sammassimo, Federica Gigli, Elisabetta Todisco, Corrado Tarella, Fabio Giglio, Enrico Derenzini
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000974024.68737.d2
_version_ 1797280927463768064
author Viviana Amato
Stefania Fusani
Cristina Papayannidis
Jacopo Nanni
Antonio Curti
Francesco Marchesi
Maurizio Fanciulli
Giorgia Simonetti
Gerardo Musuraca
Giovanni Marconi
Michele Gottardi
Alessandra Sperotto
Alessandra Rossi
Alessio Maria Edoardo Maraglino
Simona Sammassimo
Federica Gigli
Elisabetta Todisco
Corrado Tarella
Fabio Giglio
Enrico Derenzini
author_facet Viviana Amato
Stefania Fusani
Cristina Papayannidis
Jacopo Nanni
Antonio Curti
Francesco Marchesi
Maurizio Fanciulli
Giorgia Simonetti
Gerardo Musuraca
Giovanni Marconi
Michele Gottardi
Alessandra Sperotto
Alessandra Rossi
Alessio Maria Edoardo Maraglino
Simona Sammassimo
Federica Gigli
Elisabetta Todisco
Corrado Tarella
Fabio Giglio
Enrico Derenzini
author_sort Viviana Amato
collection DOAJ
first_indexed 2024-03-07T16:47:13Z
format Article
id doaj.art-71811192e9ff4aad8ba3f752bbc1bc6e
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:47:13Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-71811192e9ff4aad8ba3f752bbc1bc6e2024-03-03T06:24:36ZengWileyHemaSphere2572-92412023-08-017e68737d210.1097/01.HS9.0000974024.68737.d2202308003-01680PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICEViviana Amato0Stefania Fusani1Cristina Papayannidis2Jacopo Nanni3Antonio Curti4Francesco Marchesi5Maurizio Fanciulli6Giorgia Simonetti7Gerardo Musuraca8Giovanni Marconi9Michele Gottardi10Alessandra Sperotto11Alessandra Rossi12Alessio Maria Edoardo Maraglino13Simona Sammassimo14Federica Gigli15Elisabetta Todisco16Corrado Tarella17Fabio Giglio18Enrico Derenzini191 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy2 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy3 University of Bologna, Dipartimento di Scienze Mediche e Chirurgiche, Bologna, Italy2 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy4 Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Roma, Italy4 Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Roma, Italy5 IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy5 IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy5 IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy6 Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto, Italy6 Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy1 European Institute of Oncology, Onco-Hematology Division, Milan, Italyhttp://journals.lww.com/10.1097/01.HS9.0000974024.68737.d2
spellingShingle Viviana Amato
Stefania Fusani
Cristina Papayannidis
Jacopo Nanni
Antonio Curti
Francesco Marchesi
Maurizio Fanciulli
Giorgia Simonetti
Gerardo Musuraca
Giovanni Marconi
Michele Gottardi
Alessandra Sperotto
Alessandra Rossi
Alessio Maria Edoardo Maraglino
Simona Sammassimo
Federica Gigli
Elisabetta Todisco
Corrado Tarella
Fabio Giglio
Enrico Derenzini
PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
HemaSphere
title PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
title_full PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
title_fullStr PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
title_full_unstemmed PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
title_short PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE
title_sort pb1792 repurposing of antibiotics inhibiting mitochondrial translation in combination with venetoclax in acute myeloid leukemia from preclinical models to clinical practice
url http://journals.lww.com/10.1097/01.HS9.0000974024.68737.d2
work_keys_str_mv AT vivianaamato pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT stefaniafusani pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT cristinapapayannidis pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT jacoponanni pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT antoniocurti pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT francescomarchesi pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT mauriziofanciulli pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT giorgiasimonetti pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT gerardomusuraca pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT giovannimarconi pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT michelegottardi pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT alessandrasperotto pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT alessandrarossi pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT alessiomariaedoardomaraglino pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT simonasammassimo pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT federicagigli pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT elisabettatodisco pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT corradotarella pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT fabiogiglio pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice
AT enricoderenzini pb1792repurposingofantibioticsinhibitingmitochondrialtranslationincombinationwithvenetoclaxinacutemyeloidleukemiafrompreclinicalmodelstoclinicalpractice